Eisai to launch breast cancer drug in India

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Nov, 2013

Singapore: With an agenda to expand its footprint in the emerging markets, Japan's Eisai Pharma is launching its novel a...Read more

Prana Biotech readies to progress PBT2 to market

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

Singapore: Australia-based Prana Biotechnology is to make senior appointments as it prepares to advance its key drug to ...Read more

Oramed recruits patients for oral insulin trial

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 Aug, 2013

Singapore: Oramed Pharmaceuticals initiated patient recruitment for a new clinical trial of its orally ingestible insuli...Read more

GlobalData: New Zealand focuses on generics

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 27 Feb, 2013

Singapore: A new study by GlobalData has revealed that New Zealand's Pharmaceutical Management Agency's (PHARMAC) is emp...Read more

Allied to soon get CE mark approval from EU

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Feb, 2013

Singapore: Australia's Allied Healthcare is progressing in the regulatory process for obtaining European CE Mark approva...Read more

Rockefeller University finds genetic link to autism

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 14 Dec, 2012

Singapore: A collaborative research effort at Duke University Medical Center and Rockefeller University has pinpointed t...Read more

GSK, Theravance COPD drug gets FDA nod

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 19 Apr, 2013

Singapore: The US FDA's Pulmonary-Allergy Drugs Advisory Committee (PADAC) has approved GlaxoSmithKline (GSK) and Therav...Read more

Bayer gets Japan's nod for gastro tumor drug

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 22 Aug, 2013

Singapore: Bayer has received Japan's approval for Stivarga indicated for the treatment of patients suffering from gastr...Read more

Theravance, Alfa Wassermann collaborate

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2012

Singapore: Theravance and Alfa Wassermann entered into an exclusive development and commercialization agreement in cert...Read more

Epilepsy Foundation asks DEA to better review process

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 22 Aug, 2013

Singapore: Epilepsy Foundation of US has called on the Drug Enforcement Administration (DEA), US, to revise its process ...Read more

Fight against TB needs $1.6 bn funding annually

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Mar, 2013

Singapore: WHO and the Global Fund to Fight AIDS, TB and Malaria said that strains of tuberculosis with resistance to mu...Read more

Daiichi to aid drug discovery projects

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 12 Mar, 2013

Singapore: Daiichi Sankyo has launched TaNeDS (Take a New challenge for Drug diScovery) collaborative drug discovery pro...Read more

Queensland to get a new drug development center

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jun, 2015

Singapore: At the recent international BIO Conference in Philadelphia, Queensland's Premier Ms Annastacia Palaszczuk ann...Read more

FDA follows EU, declares Patrys drug as 'orphan'

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Nov, 2013

Singapore: Australia-based Patrys, a clinical stage biotechnology company, has received confirmation of Orphan Medicinal...Read more

AbbVie, Galapagos to make drugs for cystic fibrosis mutations

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Sep, 2013

Singapore: Europe-based Galapagos and AbbVie entered into a global alliance to discover, develop and commercialize novel...Read more

Mylan to produce generic of Gilead's HIV drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Aug, 2012

Singapore: Mylan signed a new agreement between its subsidiary Mylan Laboratories and Gilead Sciences. According top thi...Read more

MNCs bet on China to tide over patent cliff

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 16 May, 2012

Even as most emerging economies in Asia Pacific are trying to grab a foothold in the global biopharma space, China has e...Read more

Anaphore changes corporate name to RuiYi

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Oct, 2012

Singapore: Anaphore changed its corporate name to RuiYi. As part of the company's shift in strategy to the R&D of n...Read more